Update on lipoprotein(a) as a cardiovascular risk factor and mediator. - Wikidata - wikimedia - TriplyDB

Update on lipoprotein(a) as a cardiovascular risk factor and mediator.

Update on lipoprotein(a) as a cardiovascular risk factor and mediator.

http://www.wikidata.org/entity/Q38132701

about

Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.Lipoprotein(a) as a therapeutic target in cardiovascular disease.Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis.Raloxifene Lowers Plasma Lipoprotein(a) Concentrations: a Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials.Lipoprotein(a): A Lipoprotein Whose Time Has Come.Lipoprotein (a) level, apolipoprotein (a) size, and risk of unexplained ischemic stroke in young and middle-aged adults Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases - Some answers and still many questions.Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease Lipoprotein(a) Levels in Patients With Abdominal Aortic Aneurysm

P2860

Q28258969-26607428-4935-454D-BD6A-914D66F36422 Q36696683-1FCD5F10-B618-4EFC-89B3-91B7674AA6E1 Q37282484-B4986EB5-5BC9-4B6E-B4C4-84B8DA71C664 Q38213476-384919C7-9F68-42B5-9101-DF7D2A8C4FF3 Q38701405-4C618466-FEF3-4F02-B7AD-A9245CD0B599 Q38925742-B4DDF9A0-AD9D-42ED-A96A-DD4003AB0310 Q39308941-B6A1AB58-49B7-4EE1-8197-085F52FDD207 Q40601888-F8AA12B1-543C-4791-AD0C-1AF095B40683 Q40757066-D001A3F3-EB02-4F86-8DED-AF88B4FD5FCD Q58803104-A92BF5F4-B9C6-47BE-BCD0-1994C42750BB Q58886358-D46348AF-DE80-435B-8589-29262FA991AB

P2860

Update on lipoprotein(a) as a cardiovascular risk factor and mediator.

http://www.wikidata.org/entity/Q38132701

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Update on lipoprotein(a) as a cardiovascular risk factor and mediator.

@en

type

label

Update on lipoprotein(a) as a cardiovascular risk factor and mediator.

@en

prefLabel

Update on lipoprotein(a) as a cardiovascular risk factor and mediator.

@en

P1433

Q38132701-B0D34E19-8DD4-4F5D-B98C-75C8AF42F5CA

P1476

Q38132701-6A03CE42-0FF8-4F3C-8AEF-C419488A5152

P2093

Q38132701-9DA6B467-B676-4AF2-BB63-56DFE36DE008

P2860

Q38132701-015758A9-4245-4FDA-B21A-0408A47184F9

Q38132701-0317BF0F-DC48-4041-AE7B-AA4384965268

Q38132701-0E1525F0-7DE2-4572-8408-44DA922353C7

Q38132701-0FD20068-C781-4C23-BB82-B38876083BF0

Q38132701-1077C8F6-ED91-4132-BC0E-EDCF8A9002C5

Q38132701-11A30E8A-0717-4A4C-972D-6498B2FBA1CA

Q38132701-15520ED7-BB70-408B-A338-D1E8747B9916

Q38132701-1DDEAD7E-3FFB-46A3-8804-34F4CEDE1354

Q38132701-1E04936C-B27D-4169-A6A5-9C9F308C02BB

Q38132701-205B9FAC-5484-4B51-B419-00214DB4D570

P2888

Q38132701-22567E70-A75E-492D-BB7B-B8DC9071C29B

P304

Q38132701-798D259E-95CF-4E03-9B3A-017C476E5961

P31

Q38132701-0A7A8277-1843-4A18-ABC7-310E7CD97BD0

P356

Q38132701-6DF12E94-B0FD-4A83-A721-B16CCF20AA86

P433

Q38132701-C7528241-2DAE-4EB6-90B0-C9DCB4E6BDEF

P478

Q38132701-F242ECD7-8C21-4BE6-8315-84A1AE01AF15

P50

Q38132701-66BCCCF9-C554-4972-B2C4-A66654760182

P577

Q38132701-288AECC1-8B90-4288-A25A-A04EA1A0248E

P6179

Q38132701-A31F92AA-CF82-4D30-AEC0-EA93E202893E

P698

Q38132701-C7C97CE1-A002-4198-BA34-25C128B9F72C

P921

Q38132701-6776ECFB-0872-4994-9980-7A5C8D9262DE

Q38132701-BEF52506-C7BF-4847-8596-BECDBC9C6F0F

Q38132701-F2690E05-B8D4-4C83-93A4-AB6CC9DF0ED3

P356

S11883-013-0360-6

P1433

Current Atherosclerosis Reports

P1476

Update on lipoprotein(a) as a cardiovascular risk factor and mediator

@en

P2093

Marlys L Koschinsky

http://www.w3.org/2001/XMLSchema#string

P2860

The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2

The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)

The PCSK9 decade

Lipoprotein(a) as a cardiovascular risk factor: current status

Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure

Antisense oligonucleotides for the treatment of dyslipidaemia

High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men

Atorvastatin decreases lipoprotein(a): a meta-analysis of randomized trials

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

P2888

s11883-013-0360-6

P304

360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11883-013-0360-6

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Michael B. Boffa

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010086882

http://www.w3.org/2001/XMLSchema#string

P698

23990263

http://www.w3.org/2001/XMLSchema#string

P921